Concepedia

Lu Sun

LS

Statistics

Publications

5

Citations

235

H-Index

5

Active since

2015

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Lu Sun is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2015–2021

5

Publications

5

MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway

Lu Sun, Zhixian Guo, Jihong Sun et al. · Biomedicine & Pharmacotherapy · 2018 · 59 citations · Full text

, , +14

Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma

Jihong Sun, Jingjing Li, Zhixian Guo et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2018 · 57 citations · Full text

, , +17

MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis

Ting Yu, Jiajian Yu, Lu Lu et al. · Cellular Oncology · 2021 · 55 citations · Full text

, , +16

Downregulation of Microrna‐148a in Cancer‐Associated Fibroblasts from Oral Cancer Promotes Cancer Cell Migration and Invasion by Targeting Wnt10b

Anjie Min, Chao Zhu, Shuping Peng et al. · Journal of Biochemical and Molecular Toxicology · 2015 · 36 citations

, , +17

miR-346 Promotes HCC Progression by Suppressing Breast Cancer Metastasis Suppressor 1 Expression

Zhixian Guo, Jingjing Li, Jihong Sun et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2018 · 28 citations · Full text

, , +17

1–5 of 5